ISSN (Print): 2328-4129

ISSN (Online): 2328-4137

Editor-in-Chief: Apply for this position




Antimicrobial Sensitivity Pattern of Escherichia coli Causing Urinary Tract Infection in Bangladeshi Patients

1Department of Microbiology, Delta Medical College

2Department of Nephrology, Bangladesh Medical College & Hospital

American Journal of Microbiological Research. 2016, 4(4), 122-125
doi: 10.12691/ajmr-4-4-3
Copyright © 2016 Science and Education Publishing

Cite this paper:
Nayareen Akhtar, Rezwanur Rahman, Shahin Sultana. Antimicrobial Sensitivity Pattern of Escherichia coli Causing Urinary Tract Infection in Bangladeshi Patients. American Journal of Microbiological Research. 2016; 4(4):122-125. doi: 10.12691/ajmr-4-4-3.

Correspondence to: Nayareen  Akhtar, Department of Microbiology, Delta Medical College. Email:


Objectives: Urinary tract infection (UTI) is a common bacterial infection in the Bangladesh community. There has been an increasing resistance by Escherichia coli to the commonly available antibiotics. The aim of the present study was to determine the prevalence of UTI, the common causative bacteria & antimicrobial susceptibility patterns of E. coli responsible for urinary tract infections (UTIs) to currently used antimicrobial agents. Methods and Results: In this study, three hundred urine specimens from clinically suspected UTI patients were collected from both outpatient and inpatient department during the period of February 2015 to January 2016 from a tertiary level hospital in the central part of country. The inclusion criteria included patients presenting with symptoms suggestive of UTI at the study site and who gave informed written consent to participate in the study. The exclusion criteria included patients on antibiotics within the last 2 weeks, and those with recent history of instrumentation. The urine samples received were processed using standard methods. Antimicrobial sensitivity patterns were performed on all E. coli isolates obtained from urine samples by disc diffusion method. Among 300 urine samples, (59%) yielded significant bacteriuria; 123 samples (41%) showed no growth. Out of 177 urine samples which showed significant bacterial growth, 72 (40.7%) samples comprised of males and 105 (59.3%) of females. Females within the age group of 20–29 years(26.67%) and elderly males of ≥60 years(34.7%) showed higher prevalence of UTI. 75.7% of isolates were found to be Escherichia coli, 7.9% Klebsiella pneumoniae, 5.6% Proteus mirabilis, Pseudomonas aeruginosa 5.1%, 1.7% Enterococci faecalis, 2.8% Staphylococci saprophyticus and 1.1% were Staphylococcus aureus. E. coli as the predominant cause of UTI, showed the highest percentage of resistance to co-trimoxazole, nalidixic acid and amoxicillin. The isolates were most sensitive to Imipenam, Meropenam, Nitrofurantoin and Amikacin. Klebsiella pneumoniae was the second most prevalent pathogen. Conclusion: E. coli was the most frequent isolate. Imipenam, Meropenam, Nitrofurantoin and Amikacin were shown to be very effective against E. coli organisms.



[1]  Levi ME, Redington J, Barth L. The Patient With Urinary Tract Infection. Manual of Nephrology 6th Edition. Lippincott Williams & Wilkins. 2005; 7: 91.
[2]  Delanghe J, Kouri TT, Huber AR, Hannemann-Pohl K, Guder WG, Lun A, et al. The role of automated urine particle flow cytometry in clinical practice. Clin Chim Acta 2000; 301: 1-18.
[3]  Johnson EK, Wolf JS. Urinary Tract Infections in Pregnancy. [Accessed October 12, 2013]; Medscape. Available from:
[4]  Patterson TF, Andriole VT. Bacteriuria in pregnancy. Infect Dis Clin North Am. 1987;1(4):807-822.
[5]  Schieve LA, Handler A, Hershow R, Persky V, Daris F. Urinary tract infection during pregnancy: its association with maternal morbidity and perinatal outcome. Am J Public Health. 1994; 84(3): 405-410.
Show More References
[6]  Gupta KAD, Hooton CL, Wobe, Stamm WE, 1999. The prevalence of antimicrobial resistance among uropathogens causing uncomplicated cystitisin young women. International Journal ofAntimicrobial agents 11: 305-308.
[7]  Nicole W, Jon DM. Deciphering Dysuria. Emerg Med. 2008; 40(9): 29.
[8]  Pezzlo M. Detection of urinary tract infection by rapid methods. Clin Microbiol Rev 1988;3:268-80.
[9]  Bonadio M, Meini M, Spetaleri P, Gilgi C. Current microbiological and clinical aspects of urinary tract infections. Eur J Urol 2001;40:439-45.
[10]  Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, III, Hauth JC, Wenstrom KD. Renal and Urinary Tract Disorders. In: Andrea Seils, Noujaim SR, Daris K., editors. Williams Obstetrics. 21st ed. New York: McGraw-Hill Medical Publishing Divsion; 2001. pp. 1251-1272.
[11]  Arias F. Abnormalities of the urinary system during pregnancy. In: Daftary SN, Bhide AG, editors.Practical Guide to High Risk Pregnancy and Delivery. A South Asian Perspective. 3rd ed. New Delhi: Elsevier; 2008. pp. 489-505.
[12]  Blondeau JM. Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment option. Drugs. 2004; 64(6): 611-28.
[13]  National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disc susceptibility tests. 7th ed. Wayne, Pennsylvania, USA: NCCLS; 2000. M2-A7.
[14]  Abdul IF, Onile BA. Bacterial isolates from urine of women in Ilorin and their antibiotic susceptibility patterns. Trop J Obstet Gynaecol. 2001;18(2):61-65.
[15]  Arias F. Abnormalities of the urinary system during pregnancy. In: Daftary SN, Bhide AG, editors.Practical Guide to High Risk Pregnancy and Delivery. A South Asian Perspective. 3rd ed. New Delhi: Elsevier; 2008. pp. 489–505.
[16]  Goldstein FW. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group. Eur J Clin Microbiol Infect Dis. 2000; 19:112-7.
[17]  Ezechi OC, Fasubaa OB, Dare FO. Antibiotic sensitivity patterns of microbial Isolates from urine of pregnant women with urinary tract infections. Trop J Obstet Gynaecol. 2003;20(2):113-115.
[18]  Ashkenazi S, EvenTov S, Samra Z, et al. Uropathogens of various childhood populations and their antibiotic susceptibility. Pediatr Infect Dis J. 1991; 10: 742-6.
[19]  Grude N, Tveten Y, Kristiansen BE. Urinary tract infections in Norway: bacterial etiology and susceptibility, a retrospective study of clinical isolates. Clin Microbiol Infect 2001;7:543-7.
[20]  Kripke C. Duration of therapy for women with uncomplicated UTI. Am Fam Physician 2005;72:2219.
[21]  Daniel F. Sahm, Clyde Thornsberry, David C. Mayfield,Mark E. Jones, James A. Karlowsky, 2001.Multidrug-Resistant Urinary Tract Isolates of Escherichia coli: Prevalence and Patient Demographics in the United States. Journal of Antimicrobial Agents Chemotherapy Vol. 45;5: 1402-1406.
[22]  Nicolle LE, 2001. Epidemiology of urinary tract infection, Journal of Infection Medicine,18:153-162.
[23]  J. G. Collee, R. S. Miles, and B. Watt, “Tests for the identification of bacteria,” in Mackie and Mc Artney Practical Medical Microbiology, J. G. Collee, A. G. Fraser, B. P. Marmion, and A. Simmons, Eds., p. 433, Churchill Livingstone, London, UK, 1996.
[24]  V. Rajalakshmi and V. Amsaveni, “Antibiotic susceptibility of bacterial pathogens isolated from diabetic patients,” International Journal of Microbiological Research, vol. 3, no. 1, pp. 30-32, 2012.
[25]  S. Sood and R. Gupta.Antibiotic resistance pattern of community acquired uropathogens at a tertiary care hospital in Jaipur, Rajasthan. Indian Journal of Community Medicine. 2012. 37(1): 39-44.
[26]  O. A. Aiyegoro, O. O. Igbinosa, I. N. Ogunmwonyi, E. Odjadjaro, O. E. Igbinosa, and A. I. Okoh, “Incidence of urinary tract infections (UTI) among children and adolescents in Ile-Ife, Nigeria,” African Journal of Microbiological Research, vol. 1, pp. 13-19, 2007.
[27]  K. C. Arul, K. G. Prakasam, D. Kumar, and M. Vijayan, “A cross sectional study on distribution of urinary tract infection and their antibiotic utilization pattern in Kerala,” International Journal of Research in Pharmaceutical and Biomedical Sciences, vol. 3, no. 3, pp. 1125-1130, 2012.
[28]  B. A. M. Adedeji and O. A. Abdulkadir. Etiology and antimicrobial resistance pattern of bacterial agents of urinary tract infections in students of tertiary institution in Yola metropolis. Advances in Biological Researchno. 2009.3. (4): 67-70.
[29]  I. Shaifali, U. Gupta, S. E. Mahmood, and J. Ahmed. Antibiotic susceptibility patterns of urinary pathogens in female outpatients. North American Journal of Medical Sciences. 2012. 4(4): 163-169.
[30]  T. M. Hooton, D. Scholes, J. P. Hughes et al.A prospective study of risk factors for symptomatic urinary tract infection in young women. The New England Journal of Medicine.1996. 335. (7): 468-474.
[31]  Jawetz, E. and Melnick, 1995. Clinical correlations: urinary tract in Medical Microbiology, 20th Ed. London, UK, PrenticeHall Intl Inc. p. 634.
[32]  S. Shankel, Urinary Tract Infections Genitourinary Disorders, The Merck Manuals Online Medical Library, 2007.
[33]  K. Shigemura, K. Tanaka, H. Okada et al., “Pathogen occurrence and antimicrobial susceptibility of urinary tract infection cases during a 20-year period (1983-2002) at a single institution in Japan,”Japanese Journal of Infectious Diseases, vol. 58, no. 5, pp. 303-308, 2005.
[34]  M. Dash, S. Padhi, I. Mohanty, P. Panda, and B. Parida, “Antimicrobial resistance in pathogens causing urinary tract infections in a rural community of Odisha, India,” Journal of Family and Community Medicine, vol. 20, no. 1, pp. 20-26, 2013.
[35]  O. Omigie, L. Okoror, P. Umolu, and G. Ikuuh, “Increasing resistance to quinolones: a four-year prospective study of urinary tract infection pathogens,” International Journal of General Medicine, vol. 2, pp. 171-175, 2009.
[36]  E. M. Abubakar, “Antimicrobial susceptibility pattern of pathogenic bacteria causing urinary tract infections at the Specialist Hospital, Yola, Adamawa State, Nigeria,” Journal of Clinical Medicine Research, vol. 1, no. 1, pp. 001-008, 2009.
[37]  Johnson JR.Virulence factors in Escherichia coli urinary tract infection.Clin Microbiol Rev.1991;4(1):80-128.
[38]  M. Sharifian, A. Karimi, S. R. Tabatabaei, and N. Anvaripour, “Microbial sensitivity pattern in urinary tract infections in children: a single center experience of 1,177 urine cultures, Japanese Journal of Infectious Diseases, vol. 59, no. 6, pp. 380-382, 2006.
[39]  E. M. Abubakar, “Antimicrobial susceptibility pattern of pathogenic bacteria causing urinary tract infections at the Specialist Hospital, Yola, Adamawa State, Nigeria,” Journal of Clinical Medicine Research, vol. 1, no. 1, pp. 001-008, 2009.
[40]  J. C. Uwaezuoke and N. Ogbulie, “Antibiotic sensitivity pattern of urinary tract pathogens in Port-Harcourt, Nigeria,” Journal of Applied Sciences and Environmental Management, vol. 10, no. 3, pp. 103-107, 2006.
[41]  Majumder MI, Ahmed T, Hossain D, Begum SA. Bacteriology and antibiotic sensitivity patterns of urinary tract infections in a tertiary hospital in Bangladesh. Mymensingh Med J. 2014 Jan; 23(1):99-104.
[42]  Khotaii Q, Mamishi S, Saligeh RN. Antibiotic resistance of germs isolated from urinary tract infections. Iran J Pediatr 2002;12:28-32.
[43]  Garau J, Xercavins M, Rodriguez-Carballeira M, Gomez-Vera JR, Coll I, Vidal D, et al. Emergence and dissemination of quinoloneresistant Escherichia coli in the community. Antimicrob Agents Chemother 1999; 43: 2736-41.
[44]  Natsch S, Conrad C, Hartmeier C, Schmid B. Use of amoxicillin-clavulanate and resistance in Escherichia coli over a 4-year period. Infect Control Hosp Epidemiol 1998;19:653-6.
[45]  N. Goel, U. Chaudhary, R. Aggarwal, and K. Bala, “Antibiotic sensitivity pattern of gram negative bacilli isolated from the lower respiratory tract of ventilated patients in the intensive care unit,” Indian Journal of Critical Care Medicine, vol. 13, no. 3, pp. 148-151, 2009.
[46]  M.-L. Joly-Guillou, M. Kempf, J.-D. Cavallo et al., “Comparative in vitro activity of Meropenem, Imipenem and Piperacillin /tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study,” BMC Infectious Diseases, vol. 10, article 1471, 2010
[47]  A. J. Al-Zahran and N. Akhtar, “Susceptibility patterns of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae isolated in a teaching hospital,” Pakistan Journal of Medical Research, vol. 44, pp. 64-67, 2005.
Show Less References


Antibiotics Susceptibility Pattern and Plasmid Profile of Bacteria Isolated from Public Motorcycle Helmets

1Department of Microbiology, Federal University of Agriculture, PMB 2240 Abeokuta, Nigeria

2Department of Biological Sciences, Yaba College of Technology, PMB 2011, Lagos, Nigeria

3Department of Medical Microbiology and Parasitology, College of Medicine, University of Lagos, PMB 12003, Idiaraba, Lagos, Nigeria

4Molecular Biology and Biotechnology Division, the National Institute of Medical Research, PMB 2013, Yaba, Lagos, Nigeria

American Journal of Microbiological Research. 2016, 4(4), 126-131
doi: 10.12691/ajmr-4-4-4
Copyright © 2016 Science and Education Publishing

Cite this paper:
Obinna Ezeokoli, Leonard Adamu, Faustina Ezeamaramu, Godwin Ovioma, Joy Oladele, Muinah Fowora, Margaret Ugo-Ijeh, Jude Iyile. Antibiotics Susceptibility Pattern and Plasmid Profile of Bacteria Isolated from Public Motorcycle Helmets. American Journal of Microbiological Research. 2016; 4(4):126-131. doi: 10.12691/ajmr-4-4-4.

Correspondence to: Leonard  Adamu, Department of Biological Sciences, Yaba College of Technology, PMB 2011, Lagos, Nigeria. Email:


The shared use of motorcycle helmets amongst commuters could serve as a source of spread of antibiotic resistant bacteria. In this study, the antibiotic susceptibility pattern and plasmid profile of bacteria isolated from motorcycle helmets in Lagos, Nigeria were investigated. Bacteria were isolated from forty randomly sampled motorcycle helmets and characterized using morphological and biochemical tests. A total of 83 isolates belonging to the phyla Firmicutes (74.7%) and Proteobacteria (25.3%) were obtained, and included species such as Bacillus subtilis, Bacillus anthracis, Escherichia coli, Klebsiella spp., Pseudomonas aeruginosa, Salmonella spp., Shigellla spp., Staphylococcus aureus, and Staphylococcus spp. We identified species with multiple resistance patterns to commonly used antibiotics such as the β-lactams: augumentin, amoxicillin and cloxacilin, as well as the broad spectrum antibiotics gentamicin. The calculated multiple antibiotic resistance index ranged from 0.3 to 1.0. A number of the isolated species had plasmid DNA which on curing, influenced the overall sensitivity of bacteria to antibiotics. These results suggests (without outright proof) presence of antibiotic resistant plasmids in commercial motorcycle helmets and points to the possible role of plasmids in the response of bacteria to antibiotics tested. Findings of this study further highlights the epidemiological significance of motorcycle helmets sharing amongst commuters.



[1]  Perreten V, Schwarz F, Cresta L, Boeglin M, Dasen G, Teuber M. Antibiotic resistance spread in food. Nature 389: 801-802 (1997).
[2]  Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Annals of internal medicine 134: 298-314 (2001).
[3]  Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. The lancet 358: 135-138 (2001).
[4]  Normark BH, Normark S. Evolution and spread of antibiotic resistance. Journal of internal medicine 252: 91-106 (2002).
[5]  Adamu L, Edeghagba B, Olatomi F, Ezeokoli O, Elijah A. Microorganisms associated with commercial motorcycle helmets in Lagos metropolis. Journal of Microbiology, Biotechnology and Food Sciences 1: 1179-1188 (2012).
Show More References
[6]  Adamu GOL, Edeghagba B, Abiola OM, Elijah AI, Ezeokoli OT. Antimicrobial activity of extracts of Jatropha curcas and Calotropis procera leaves against pathogenic isolates from motorcycle helmets in Lagos metropolis. International Journal of Current Microbiology and Applied Sciences 2: 292-302 (2013).
[7]  Roth R, Jenner W. Microbial ecology of the skin. Annual Review of Microbiology 42: 441-464 (1998).
[8]  Neu HC. The crisis in antibiotic resistance. Science 257: 1064-1073 (1992).
[9]  Andersson DI, Levin BR. The biological cost of antibiotic resistance. Current opinion in microbiology 2: 489-493 (1999).
[10]  McGowan JEJ. Economic Impact of Antimicrobial Resistance. Emerging infectious diseases 7: 286-292 (2001).
[11]  Smith DL, Dushoff J, Perencevich EN, Harris AD, Levin SA. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proceedings of the National Academy of Sciences of the United States of America 101: 3709-3714 (2004).
[12]  Heuer H, Schmitt H, Smalla K. Antibiotic resistance gene spread due to manure application on agricultural fields. Current opinion in microbiology 14: 236-243 (2011).
[13]  Baquero F, Martínez J-L, Cantón R. Antibiotics and antibiotic resistance in water environments. Current opinion in biotechnology 19: 260-265 (2008).
[14]  Wang M, Tran JH, Jacoby GA, Zhang Y, Wang F, Hooper DC. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrobial agents and chemotherapy 47: 2242-2248 (2003).
[15]  Harrison E, Brockhurst MA. Plasmid-mediated horizontal gene transfer is a co-evolutionary process. Trends in microbiology 20: 262-267 (2012).
[16]  Alessandra C. Resistance plasmids families in enterobacteriacae. Microbial Agent and Chemotherapy 53: 2227-2238 (2009).
[17]  Svara F, Rankin DJ. The evolution of plasmid-carried antibiotic resistance. BMC evolutionary biology 11: 130 (2011).
[18]  Bauer A, Kirby W, Sherris JC, Turck, Turck M. Antibiotic susceptibility testing by a standardized single disk method. American journal of clinical pathology 45: 493 (1966).
[19]  CLSI. Performance Standards for Antimicrobial Susceptibility testing; twenty second informmational supplement. CLSI, Pennyslvania, USA (2012).
[20]  Poonia S, Singh TS, Tsering DC. Antibiotic Susceptibility Profile of Bacteria Isolated from Natural Sources of Water from Rural Areas of East Sikkim. Indian Journal of Community Medicine 39: 156-160 (2014).
[21]  Christopher A, Hora S, Ali Z. Investigation of plasmid profile, antibiotic susceptibility pattern multiple antibiotic resistance index calculation of Escherichia coli isolates obtained from different human clinical specimens at tertiary care hospital in Bareilly-India. Annals of Tropical Medicine and Public Health 6: 285-289 (2013).
[22]  Zhou C, Yujun Y, Jong AY. Mini-prep in ten minutes. Bio. Techniques 8: 172-173 (1990).
[23]  Akortha EE, Filgona J. Transfer of gentamicin resistance genes amongenterobacteriaceae isolated from the outpatients with urinary tract infections attending 3hospitals in Mubi, Adamawa State. Scientific Research and Essay 4: 745-752 (2009).
[24]  Willey JM, Sherwood LM, Woolverton CJ. Prescotts Microbiology. McGraw hill, New York (2011).
[25]  Devaux I, Varela-Santos C, Payne-Hallstrom L, Takkinen J, Bogaardt C, Coulobier D. Investigation of travel-related cases in a multinational outbreak: example of the Shiga-toxin producing E. coli outbreak in Germany, May-June 2011. Epidemiology and Infection 143: 3468-3474 (2015).
[26]  Ferdinandus J, Hensckhe K, Palombo EA. Isolation of pathogenic bacteria and opportunistic pathogens from public telephones. Environmental Health 1: 74-79 (2001).
[27]  Yusha'u M, Bello M, Sule H. Isolation of bacteria and fungi from personal and public mobile cellphones: A case study of Bayero University, Kano (Old Campus). International Journal of Biomedical and Health Sciences 6: 97-102 (2010).
[28]  Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerging infectious diseases 7: 178 (2001).
[29]  Hartman BJ, Tomasz A. Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. Journal of Bacteriology 158: 513-516 (1984).
[30]  Ogunshe A, Niemogha M, Azum G, Odikagbue A. Microbiological evaluation of antibiotic resistance in bacterial flora from skin wounds. Journal of Pharmaceutical and Biomedical Sciences 22: 1-7 (2012).
[31]  Heuer H, Krögerrecklenfort E, Wellington E, Egan S, Van Elsas J, Van Overbeek L, Collard J-M, Guillaume G, Karagouni A, Nikolakopoulou T. Gentamicin resistance genes in environmental bacteria: prevalence and transfer. FEMS microbiology ecology 42: 289-302 (2002).
[32]  Tjaniadi P, Lesmana M, Subekti D, Machpud N, Komalarini S, Santoso W, Simanjuntak CH, Punjabi N, Campbell JR, Alexander WK, Beecham HJ, Corwin AL, Oyofo BA. Antimicrobial Resistance of Bacterial Pathogens Assosiated with Diarrheal Patients in Indonesia. American Journal of Tropical Medicine and Hygiene 68: 666-670 (2003).
[33]  Tagoe DN, Adams L, Kangah V. Antibiotic Resistant Bacterial Contamination of the Ghanaian Currency Note: A Potential Health Problem. Journal of Microbiology and Biotechnology Research 1: 37-44 (2011).
[34]  Hemen JT, Johnson JT, Ambo EE, Ekam VS, Odey MO, Fila WA. Multi-Antibiotic Resistance of Some Gram Negative Bacterial Isolates from Poultry Litters of Selected Farms in Benue State. IJST 2: 543-547 (2012).
Show Less References


Synergistic Effect of Biogenic Silver-nanoparticles with β. lactam Cefotaxime against Resistant Staphylococcus arlettae AUMC b-163 Isolated from T3A Pharmaceutical Cleanroom, Assiut, Egypt

1Department of Botany and Microbiology, Faculty of Science, Assiut University, Egypt

American Journal of Microbiological Research. 2016, 4(5), 132-137
doi: 10.12691/ajmr-4-5-1
Copyright © 2016 Science and Education Publishing

Cite this paper:
M. H. A. Hassan, M.A. Ismail, A.M. Moharram, A. Shoreit. Synergistic Effect of Biogenic Silver-nanoparticles with β. lactam Cefotaxime against Resistant Staphylococcus arlettae AUMC b-163 Isolated from T3A Pharmaceutical Cleanroom, Assiut, Egypt. American Journal of Microbiological Research. 2016; 4(5):132-137. doi: 10.12691/ajmr-4-5-1.

Correspondence to: A.  Shoreit, Department of Botany and Microbiology, Faculty of Science, Assiut University, Egypt. Email:


The aim of this study was to biosynthesis silver nanoparticles (AgNPs) from Staphylococcus arlettae AUMC b-163 isolated from T3A pharmaceutical company cleanroom, its antimicrobial activity, and the synergistic effect of AgNPs in combination with commonly used antibiotic Cefotaxime sodium against resistant bacteria. The synthesized AgNPs from bacterial were characterized by using UV-VS spectrophotometer analysis, Fourier Transform Infrared Spectroscopy (FTIR), X-ray diffraction (XRD) and Transmission Electron Microscopy (TEM).UV-VS spectrophotometer analysis showed a peak at 420 nm corresponding to the Plasmon absorbance of silver nanoparticles and FTIR analysis showed the potential biomolecule responsible for the reduction of silver. The structural properties of silver nanoparticles were confirmed using XRD technique, while TEM micrographs revealed that the silver nanoparticles are dispersed and aggregated, and mostly having spherical shape within the size range between 8 and 35 nm. The synthesized silver nanoparticles exhibited a varied growth inhibition activity against the tested pathogenic bacteria. A significant increase in area of growth inhibition was observed when a combination of silver nanoparticles and Cefotaxime antibiotics was applied. The current results revealed that the synthesized silver nanoparticles produced by the bacterial strain Staphylococcus arlettae AUMC b-163 is a promising to be used in medical therapy due to their broad spectrum against some pathogenic bacteria, fungi and resistant tested bacteria.



[1]  Wright, GDs, “Bacterial resistance to antibiotics: enzymatic degradation and modification” Advanced drug delivery reviews, 57 (10), 1451-1470, 2005.
[2]  Dar, MA.; Ingle A.; Rai Ms, “Enhanced antimicrobial activity of silver nanoparticles synthesized by Cryphonectria sp. evaluated singly and in combination with antibiotics” Nanomedicine: Nanotechnology, Biology and Medicine, 9 (1), 105-110, 2013.
[3]  Fayaz, AM.; Balaji K.; Girilal M.; Yadav R.; Kalaichelvan PT.; Venketesan Rs, “Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria” Nanomedicine: Nanotechnology, Biology and Medicine, 6 (1), 103-109, 2010.
[4]  Geoprincy, G.; Saravanan P.; Gandhi NN.; Renganathan Ss, “A novel approach for studying the combined antimicrobial effects of silver nanoparticles and antibiotics through agar over layer method and disk diffusion method” Digest Journal of Nanomaterials and Biostructures, 6 (4), 1557-1565, 2011.
[5]  Shahverdi, AR.; Fakhimi A.; Shahverdi HR.; Minaian Ss, “Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics againstStaphylococcus aureus and Escherichia coli Nanomedicine: Nanotechnology, Biology and Medicine, 3 (2), 168-171, 2007.
Show More References
[6]  Kalimuthu, K.; Suresh Babu R.; Venkataraman D.; Bilal M.; Gurunathan Ss, “Biosynthesis of silver nanocrystals by Bacillus licheniformis Colloids and Surfaces B: Biointerfaces, 65 (1), 150-153, 2008.
[7]  Bhainsa, KC.; D'souza Ss, “Extracellular biosynthesis of silver nanoparticles using the fungus Aspergillus fumigatus Colloids and Surfaces B: Biointerfaces, 47 (2), 160-164, 2006.
[8]  Nanda, A.; Saravanan Ms, “Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE” Nanomedicine: Nanotechnology, Biology and Medicine, 5 (4), 452-456, 2009.
[9]  Kim, JS.; Kuk E.; Yu KN.; Kim J-H.; Park SJ.; Lee HJ.; Kim SH.; Park YK.; Park YH.; Hwang C-Ys, “Antimicrobial effects of silver nanoparticles”Nanomedicine: Nanotechnology, Biology and Medicine, 3 (1), 95-101, 2007.
[10]  Singh, M.; Manikandan S.; Kumaraguru As, “Nanoparticles: A new technology with wide applications” Res J Nanosci Nanotechnol, 1 (1), 1-11, 2011.
[11]  Arya, V.; Komal R.; Kaur M.; Goyal A.; Town Ms, “Silver nanoparticles as a potent antimicrobial agent: a review” Pharmacologyonline, 3 118-124, 2011.
[12]  Ljungqvist, B.; Reinmüller Bs, “Airborne viable particles and total number of airborne particles: comparative studies of active air sampling” PDA Journal of Pharmaceutical Science and Technology, 54 (2), 112-116, 2000.
[13]  White, TJ.; Bruns T.; Lee S.; Taylor Js, “Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics” PCR protocols: a guide to methods and applications, 18 315-322, 1990.
[14]  Gurunathan, S.; Kalishwaralal K.; Vaidyanathan R.; Venkataraman D.; Pandian SRK.; Muniyandi J.; Hariharan N.; Eom SHs, “Biosynthesis, purification and characterization of silver nanoparticles using Escherichia coli Colloids and Surfaces B: Biointerfaces, 74 (1), 328-335, 2009.
[15]  Saifuddin, N.; Wong C.; Yasumira As, “Rapid biosynthesis of silver nanoparticles using culture supernatant of bacteria with microwave irradiation” Journal of Chemistry, 6 (1), 61-70, 2009.
[16]  Silambarasan, S.; Jayanthi As, “Biosynthesis of silver nanoparticles using Pseudomonas fluorescens Research Journal of Biotechnology Vol, 8 3, 2013.
[17]  Prema, P.; Raju Rs, “Fabrication and characterization of silver nanoparticle and its potential antibacterial activity” Biotechnology and Bioprocess Engineering, 14 (6), 842-847, 2009.
[18]  Perez, C.; Pauli M.; Bazerque Ps, “An antibiotic assay by the agar well diffusion method” Acta Biol Med Exp, 15 113-115, 1990.
[19]  Li, P.; Li J.; Wu C.; Wu Q.; Li Js, “Synergistic antibacterial effects of β-lactam antibiotic combined with silver nanoparticles” Nanotechnology, 16 (9), 1912, 2005.
[20]  Davies, RL.; Etris SFs, “The development and functions of silver in water purification and disease control” Catalysis Today, 36 (1), 107-114, 1997.
[21]  Narasimha, G.; Praveen B.; Mallikarjuna K.; Deva Prasad Raju Bs, “Mushrooms (Agaricus bisporus) mediated biosynthesis of sliver nanoparticles, characterization and their antimicrobial activity” International Journal of Nano Dimension, 2 29-36, 2011.
[22]  Sondi, I.; Salopek-Sondi Bs, “Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria” Journal of colloid and interface science, 275 (1), 177-182, 2004.
[23]  Lara, HH.; Ayala-Núnez NV.; Turrent LdCI.; Padilla CRs, “Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria” World Journal of Microbiology and Biotechnology, 26 (4), 615-621, 2010.
[24]  Rai, M.; Deshmukh S.; Ingle A.; Gade As, “Silver nanoparticles: the powerful nanoweapon against multidrug‐resistant bacteria” Journal of applied microbiology, 112 (5), 841-852, 2012.
[25]  Kollef, MH.; Golan Y.; Micek ST.; Shorr AF.; Restrepo MIs, “Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections–proceedings and data from the Gram-Negative Resistance Summit” Clinical infectious diseases, 53 (suppl 2), S33-S55, 2011.
[26]  Senapati, S.; Ahmad A.; Khan MI.; Sastry M.; Kumar Rs, “Extracellular biosynthesis of bimetallic Au–Ag alloy nanoparticles” Small, 1 (5), 517-520, 2005.
Show Less References